Back
Palatin Technologies 10K Form
Sell
1
PTN
Palatin Technologies
Last Price:
0.84
Seasonality Move:
-11.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-02-16 | 10Q | PTN/Palatin Technologies Quarterly |
2020-11-16 | 10Q | PTN/Palatin Technologies Quarterly |
2020-09-25 | 10K | PTN/Palatin Technologies Annual |
2020-05-11 | 10Q | PTN/Palatin Technologies Quarterly |
2020-02-10 | 10Q | PTN/Palatin Technologies Quarterly |
2019-11-12 | 10Q | PTN/Palatin Technologies Quarterly |
Receive PTN News And Ratings
See the #1 stock for the next 7 days that we like better than PTN
PTN Financial Statistics
Sales & Book Value
Annual Sales: | $4.85M |
---|---|
Cash Flow: | $-8.61M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.10 |
Price / Book: | 10.31 |
Profitability
EPS (TTM): | -2.76000 |
---|---|
Net Income (TTM): | $-35.49M |
Gross Margin: | $4.44M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Palatin Technologies Earnings Forecast
Key Palatin Technologies Financial Ratios
- The Gross Profit Margin over the past 27 years for PTN is 91.38%.
- The Selling, General & Administrative Expenses for PTN have been equal to 315.04% of Gross Profit Margin.
- The Research & Development expenses have been 466.26% of Revenue.
- The Interest Expense is -0.07% of Operating Income.
- The Net Earning history of PTN is -567.44% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 18 years.
Palatin Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | PTN |
CUSIP: | 696077 |
Website: | palatin.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 1.28 |
PTN Technical Analysis vs Fundamental Analysis
Sell
1
Palatin Technologies (PTN)
is a Sell
Is Palatin Technologies a Buy or a Sell?
-
Palatin Technologies stock is rated a Sell
The current Palatin Technologies [PTN] share price is $0.84. The Score for PTN is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.